Science Explorer Back to mapMap
Discussion
Topic · Oncology

Viral-associated cancers and disorders

Viral-associated cancers and disorders is a research topic within Oncology. Science Explorer counts 34k research works in it since 1951. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the incidence, risk factors, and management of viral-related cancers, particularly associated with Epstein-Barr virus (EBV) and Kaposi's Sarcoma-associated herpesvirus (KSHV), in immunocompromised individuals such as HIV/AIDS patients and transplant recipients. It explores the impact of immunosuppression, antiretroviral therapy, and viral reactivation on cancer development, as well as the use of targeted therapies and immune-based treatments for these malignancies.

  • Epstein-Barr Virus
  • Kaposi's Sarcoma
  • HIV/AIDS
  • Transplant Recipients
  • Lymphoproliferative Disorders
  • Human Herpesvirus 8
  • Cancer Incidence
  • Immunosuppression
  • Post-Transplant Lymphoproliferative Disease
  • Viral Oncogenesis
Research works
34k
fractional, since 1951
In the world top 10%
3.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+1%
the tick is no change
Largest producer
United States
37% of the 10 largest, 2022-now
Viral-associated cancers and disorders

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Viral-associated cancers and disorders research?

By volume, the United States and China publish the most (1.5k and 1k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.5k works
  2. 2 China 1k works
  3. 3 Japan 346 works
  4. 4 India 222 works
  5. 5 Italy 178 works
  6. 6 Brazil 167 works
  7. 7 France 153 works
  8. 8 Germany 137 works
  9. 9 United Kingdom 135 works
  10. 10 Spain 121 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 37.1%China: 26.3%Japan: 8.7%India: 5.6%6 others listed: 22.3%37%largest
United States1,480 · 37.1%China1,049 · 26.3%Japan346 · 8.7%India222 · 5.6%6 others listed891 · 22.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Viral-associated cancers and disorders research?

By volume in 2022-now, Sun Yat-sen University publishes the most Viral-associated cancers and disorders research, followed by Harvard University and National Institutes of Health.

By volume, 2022-now

  1. 1 Sun Yat-sen UniversityChina 69 works
  2. 2 Harvard UniversityUnited States 50 works
  3. 3 National Institutes of HealthUnited States 48 works
  4. 4 Mayo ClinicUnited States 43 works
  5. 5 Capital Medical UniversityChina 36 works
  6. 6 Sichuan UniversityChina 35 works
  7. 7 University of North Carolina at Chapel HillUnited States 35 works
  8. 8 Zhejiang UniversityChina 34 works
  9. 9 The University of Texas MD Anderson Cancer CenterUnited States 34 works
  10. 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 32 works

Who are the leading researchers in Viral-associated cancers and disorders?

The most-cited researchers publishing on Viral-associated cancers and disorders include Ahmedin Jemal, Freddie Bray and Jacques Ferlay.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Jacques Ferlay France 486k citations
  4. 4 Mark J. Daly United States 403k citations
  5. 5 Robert John Tibshirani United States 396k citations
  6. 6 Gad A. Getz United States 364k citations
  7. 7 Elaine R. Mardis United States 346k citations
  8. 8 Hermann Brenner Germany 343k citations
  9. 9 Shizuo Akira Japan 342k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Viral-associated cancers and disorders?

The most cited paper in Viral-associated cancers and disorders is "Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis" (Vincenzo Mazzaferro, Enrico Regalia, Roberto Doci et al., 1996), with 7,221 citations. Next come "Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma" (5,746) and "Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma" (5,108).

Most cited papers
#PaperReleasedCitations
1 Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis Vincenzo Mazzaferro, Enrico Regalia, Roberto Doci et al. · New England Journal of Medicine 14 Mar 1996 7,221
2 Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma Yuan Chang, Ethel Cesarman, Melissa S. Pessin et al. · Science 16 Dec 1994 5,746
3 Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Bernard J. Poiesz, Francis W. Ruscetti, Adi F. Gazdar et al. · Proceedings of the National Academy of Sciences Open access Dec 1980 5,108
4 The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Rita Alaggio et al. · Leukemia Open access 22 Jun 2022 4,010
5 Classification of papillomaviruses Ethel-Michele de Villiers, Claude Fauquet, Thomas R. Broker et al. · Virology Open access 8 May 2004 3,233
All 100 most cited papers, with filters and sorting

Where is Viral-associated cancers and disorders research done?

The largest centres of Viral-associated cancers and disorders research in 2022-now are Beijing (China), Guangzhou (China), Tokyo (Japan) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda and Tampa.

Largest cities, 2022-now

  1. 1 BeijingChina 149 works
  2. 2 GuangzhouChina 107 works
  3. 3 TokyoJapan 81 works
  4. 4 ShanghaiChina 79 works
  5. 5 New YorkUnited States 77 works
  6. 6 ParisFrance 67 works
  7. 7 PhiladelphiaUnited States 63 works
  8. 8 HoustonUnited States 58 works
  9. 9 SeoulSouth Korea 55 works
  10. 10 ChengduChina 49 works

Where it is the local speciality

  1. BethesdaUS · 43.6 works6.8×
  2. TampaUS · 22.9 works6.3×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Viral-associated cancers and disorders than the world average.

See Viral-associated cancers and disorders on the map

Where is the best place to study Viral-associated cancers and disorders?

Among universities, judged by research, Sun Yat-sen University, Harvard University and Cornell University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.45%fractional works in this field (log) →share of work in the world top 10% →Sun Yat-sen UniversityHarvard UniversityCornell UniversityUniversity of Califo…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sun Yat-sen UniversityChina 68.123.0%7.2×69 -1.3%
2Harvard UniversityUnited States 61.920.6%3.4×50 -9.9%
3Cornell UniversityUnited States 53.515.6%4.5×28 +11.1%
4University of California, San FranciscoUnited States 53.014.1%6.1×20 +26.2%
5University of Hong KongChina 52.546.0%1.9×8 -53.3%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49.511.6%6.5×32 +20.7%
7University of PennsylvaniaUnited States 49.414.4%6.0×30 -9.4%
8Columbia UniversityUnited States 47.911.1%4.2×22 +78.4%
9Shanghai Jiao Tong UniversityChina 47.718.7%2.0×27 +27.8%
10Chinese University of Hong KongChina 47.629.4%2.6×9 -24.9%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Viral-associated cancers and disorders, country by country

Is Viral-associated cancers and disorders research growing?

Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Viral-associated cancers and disorders.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Viral-associated cancers and disorders as a percentage of every work published that year, 0.021% in 2024.

still counting0.020%0.040%0.060%Viral-associated cancers and disorders0.022% in 202519801990200020102020

Fractional works of Viral-associated cancers and disorders over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Viral-associated cancers and disorders10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Viral-associated cancers and disorders. Posts are plain text and can be reported.